title: A report from the American College of Rheumatology 2013 Meeting (October 26-30, 2013 - San Diego, California, USA).
abstract: The American College of Rheumatology annual meeting opened in San Diego, California, with a poster session in which prominent clinical and preclinical research into experimental and putative novel therapies for rheumatoid arthritis and other inflammatory conditions were discussed. The meeting continued through 2 more days of poster presentations and 4 days of very active oral sessions, in which information was discussed on therapeutics and candidate drugs for managing rheumatological diseases ranging from rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus to many other conditions frequently seen in the rheumatology ward. The following report summarizes a selection of oral and poster presentations that reflect the state of the art of current rheumatology pharmacotherapy and what is arising as novel investigational therapy.
authors.affiliation: Thomson Reuters, Barcelona, Spain. xavier.rabasseda@thomsonreuters.com.
authors.forename: X
authors.initials: X
authors.lastname: Rabasseda
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D006801:Humans; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000503:physiopathology; D012219:Rheumatology
keywords: Arthritis; Fibromyalgia; Rheumatology; Systemic lupus erythematosus